Evidence map›Paper›PMID 40673435›Full record

ArticleeLife2025

Interpretable protein-DNA interactions captured by structure-sequence optimization.

Yafan Zhang, Irene Silvernail, Zhuyang Lin, Xingcheng Lin

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yafan ZhangBioinformatics Research Center, North Carolina State University, Raleigh, United States.ORCID https://orcid.org/0000-0002-7867-2873
Irene SilvernailDepartment of Physics, North Carolina State University, Raleigh, United States.ORCID https://orcid.org/0009-0003-3070-974X
Zhuyang LinBioinformatics Research Center, North Carolina State University, Raleigh, United States.ORCID https://orcid.org/0009-0009-0480-7024
Xingcheng LinBioinformatics Research Center, North Carolina State University, Raleigh, United States.ORCID https://orcid.org/0000-0002-9378-6174

Funding

North Carolina State University Ideation fundNorth Carolina State University Interdisciplinary seed fundingNorth Carolina State University Startup funding
6 · The paper itself

Abstract

Sequence-specific DNA recognition underlies essential processes in gene regulation, yet methods for simultaneous predictions of genomic DNA recognition sites and their binding affinity remain lacking. Here, we present the Interpretable protein-DNA Energy Associative (IDEA) model, a residue-level, interpretable biophysical model capable of predicting binding sites and affinities of DNA-binding proteins. By fusing structures and sequences of known protein-DNA complexes into an optimized energy model, IDEA enables direct interpretation of physicochemical interactions among individual amino acids and nucleotides. We demonstrate that this energy model can accurately predict DNA recognition sites and their binding strengths across various protein families. Additionally, the IDEA model is integrated into a coarse-grained simulation framework that quantitatively captures the absolute protein-DNA binding free energies. Overall, IDEA provides an integrated computational platform that alleviates experimental costs and biases in assessing DNA recognition and can be utilized for mechanistic studies of various DNA-recognition processes.

Indexed as

DNADNA-Binding ProteinsBinding SitesModels, MolecularProtein BindingThermodynamicsDNADNA-Binding Proteinsdata-driven modelinggenomic binding sites predictionsmolecular biophysicsnoneprotein-DNA binding affinity predictionsequence-specific simulationstructural biologystructure-sequence integration

Identifiers

PMID40673435
PMCPMC12270484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.